Equities

Nutex Befektetesi Nyrt

  • Add to watchlist
  • Add to portfolio
  • Add an alert
0P20:LSE

Nutex Befektetesi Nyrt

Actions
  • Price (HUF)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta0.6516
Data delayed at least 20 minutes.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

NUTEX Befektetesi Nyrt is a Hungary-based company engaged in the research, development, manufacturing and distribution of medicinal products. Together with its daughter companies it forms Nutex Group. The Group also provides to its consumers health conserving, health improving, dietary supplement and cosmetic products. Its brand names include Enerex and Organic Mission. NUTEX Befektetesi Nyrt operates in Hungary, Slovakia and the United Kingdom, as well as in Canada, Taiwan, Iran, the United Arab Emirates, Mexico and Hong Kong.

  • Revenue in HUF (TTM)450.00k
  • Net income in HUF270.89m
  • Incorporated1996
  • Employees1.00
  • Location
    Nutex Befektetesi NyrtTelepes u. 53.BUDAPEST 1147HungaryHUN
  • Phone+36 18017081
  • Fax+36 18017082
  • Websitehttp://www.nutex.hu/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.